NCT06858761

Brief Summary

CONTEXT : Obesity is a serious disease which affects 17% of the french population. Bariatric and metabolic surgery has demonstrated its efficiency and remains the treatment of reference. Over 40,000 bariatric procedures are performed per year, mainly by laparoscopy ; the robotic approach, historically developed by Intuitive Surgical increases rapidly and accounts for 18% of the procedures in the public system. Whereas the robotic approach has demonstrated its superiority toward laparoscopy for prostatectomies and rectal resections, it still has to be demonstrated for bariatric surgery ; some studies report a decrease rate of complications for complexe procedures and selected patients but the literature remains variable and the benefit of the robot in relation to its high cost must be confirmed. OBJECTIVES: To conduct a health-economic assessment (i.e. cost-effectiveness ratio expressed as the additional cost per quality adjusted life-year gained) of the Da Vinci robot in bariatric surgery at 1 year, from the Health Care system point of view. METHOD : Randomized (482 patients), controlled, single-blind, multicenter, superiority trial comparing two approaches for primary or revisional bariatric surgery: a group benefiting from a robotic approach and a reference group benefiting from a laparoscopic approach. Data from the trial will be matched via the social security number to the French National Health Insurance Information System (SNDS database) in order to collect care consumption. The quality of life will be assessed using the EuroQol-5 Dimension (EQ5D-5L) questionnaire. PERSPECTIVES: This study will have a direct impact on patients care, professional practices and public health policy either by validating the value of the robot in bariatric surgery or conversely, by promoting the laparoscopic approach. HYPOTHESIS : Robot-assisted bariatric surgery is more expensive than conventional laparoscopy, but the additional costs associated with the robot are partly offset by a reduction in post-operative complications at 1 year, which should also help to improve patients' quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
482

participants targeted

Target at P75+ for not_applicable obesity

Timeline
26mo left

Started Jul 2025

Typical duration for not_applicable obesity

Geographic Reach
1 country

16 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jul 2025Jul 2028

First Submitted

Initial submission to the registry

February 20, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 5, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

July 25, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

2.9 years

First QC Date

February 20, 2025

Last Update Submit

July 28, 2025

Conditions

Keywords

ObesityBariatric surgeryRobot

Outcome Measures

Primary Outcomes (1)

  • Incremental cost-effectivEness ratio (ICER)

    Ratio expressed as additional cost per Quality Adjusted Life Year gained (cost/QALY) calculated from: * Survival and quality of life data (EQ-5D-5L questionnaire) * Cost data (micro-costing) and by individual matching with the French National Health Insurance Information System (SNDS database)

    1 year after surgery

Secondary Outcomes (17)

  • Number, type and severity of intraoperative complications

    End of the surgery

  • Number, type and severity of postoperative complications

    1, 3 and 12 months after surgery

  • Pain assessment

    1 day, 2 days and 1 month after surgery

  • Readmission rate

    1, 3 and 12 months after surgery

  • Reintervention rate

    1, 3 and 12 months after surgery

  • +12 more secondary outcomes

Study Arms (2)

Robot-assisted surgical strategy

EXPERIMENTAL

Primary bariatric surgery (According to the recommendations of the High Authority of Health: patient with a BMI ≥40 kg/m2 and/or BMI ≥35 kg/m2 associated with at least one comorbidity and/or BMI between 30 and 35 kg/m2 and suffering from type 2 diabetes) or revision bariatric surgery (for complications or side effects of a previous surgery), using a robotic approach.

Procedure: Robot-assisted surgical strategyOther: Visual analog scaleOther: EQ-5D-5L questionnaireOther: Impact of Weight on Quality of Life (IWQOL) questionnaire

Conventional laparoscopic surgical strategy

ACTIVE COMPARATOR

Primary bariatric surgery (According to the recommendations of the High Authority of Health: patient with a BMI ≥40 kg/m2 and/or BMI ≥35 kg/m2 associated with at least one comorbidity and/or BMI between 30 and 35 kg/m2 and suffering from type 2 diabetes) or revision bariatric surgery (for complications or side effects of a previous surgery), using a conventional laparoscopic approach.

Procedure: Conventional laparoscopic surgical strategyOther: Visual analog scaleOther: EQ-5D-5L questionnaireOther: Impact of Weight on Quality of Life (IWQOL) questionnaire

Interventions

Primary or revision bariatric surgery (for complications or side effects of a previous surgery), using a robotic approach. The robot used will be the Da Vinci X or Xi model (depending on the center) from the company Intuitive Surgical.

Robot-assisted surgical strategy

Primary or revision bariatric surgery (for complications or side effects of a previous surgery), using a conventional laparoscopic approach

Conventional laparoscopic surgical strategy

All patients will have pain evaluation with visual analog scale

Conventional laparoscopic surgical strategyRobot-assisted surgical strategy

All patients will have quality of life assessment with EQ-5D-5L questionnaire

Conventional laparoscopic surgical strategyRobot-assisted surgical strategy

All patients will have Quality of life assessment with IWQOL questionnaire

Conventional laparoscopic surgical strategyRobot-assisted surgical strategy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged between 18 and 70 years old,
  • Female or male patients
  • Patient eligible for one of the two situations defined below:
  • Primary bariatric or metabolic surgery, with a BMI corresponding to one of the 3 following situations, in accordance with the french National Authority for Health (HAS) recommendations published in February 2024:
  • kg/m² OR
  • kg/m² with at least one comorbidity that may improve after surgery (e.g.: high blood pressure, sleep apnea syndrome and other severe respiratory disorders, type 2 diabetes, disabling osteoarticular diseases, steatohepatitis not alcoholic, dyslipidemia, osteoarthritis) OR between 30 and 35 kg/m² with uncontrolled type 2 diabetes
  • Revision surgery for complication and/or side effects of a previous bariatric surgery
  • Patient who has benefited from a pluridisciplinary evaluation (medical, surgical, psychiatric), with a favorable opinion for a bariatric.
  • Patient who agrees to be included in the study and who signs the informed consent form,

You may not qualify if:

  • Presence of a severe and evolutive life threatening pathology, unrelated to obesity,
  • Pregnancy or desire to be pregnant during the study,
  • Patient not affiliated to a French or European healthcare insurance,
  • Patient under supervision or guardianship
  • Patient who is unable to give consent,
  • Patient who does not understand French
  • Patient who has already been included in a trial which has a conflict of interests with the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

Département de chirurgie digestive et endocrinienne Groupe Hospitalier Pellegrin Place Amélie Raba Léon 33076 BORDEAUX

Bordeaux, 33076, France

RECRUITING

Département de chirurgie digestive CHRU Dijon - Hôpital Le Bocage Bd du Maréchal de Lattre de Tassigny 21000 DIJON

Dijon, 21000, France

RECRUITING

Digestive Surgery Department CHU Grenoble BP217 - 38043 GRENOBLE Cedex 09

Grenoble, 38043, France

RECRUITING

Service de Chirurgie Générale et Digestive Grand Hopital de l'Est Francilien Site de Marne La Vallée 2-4 Cours de la Gondoire 77600 JOSSIGNY

Jossigny, 77600, France

RECRUITING

Service de Chirurgie Générale et Endocrinienne CHU de Lille - Hôpital Claude Huriez 1 rue Michel Polonovski 59000 LILLE

Lille, 59000, France

RECRUITING

Hospices Civils de Lyon - Hôpital Edouard Herriot Chirurgie Digestive et Bariatrique 5 Place d'Arsonval - 69437 Lyon Cedex 03 - FRANCE

Lyon, 69437, France

RECRUITING

Département de chirurgie digestive et bariatrique CHU de Nantes - Site Hôtel-Dieu - HME 1 Place Alexis Ricordeau 44000 NANTES

Nantes, 44000, France

RECRUITING

Département de Chirurgie digestive Hôpital de la Source CHU d'ORLEANS 14 Avenue de l'hôpital 45100 ORLEANS LA SOURCE

Orléans, 45100, France

RECRUITING

Service de Chirurgie Digestive Hépato-bilio-pancréatique et Transplantation Hépatique Chirurgie Bariatrique, coelioscopique et robotique AP-HP - Hôpital Universitaire La Pitié Salpêtrière 47-83 boulevard de l'hôpital 75013 PARIS

Paris, 75013, France

RECRUITING

Département de chirurgie digestive, oncologique et bariatrique AP-HP - Hôpital Européen Georges Pompidou 20 rue Leblanc 75015 PARIS

Paris, 75015, France

RECRUITING

Département de chirurgie digestive, œsogastrique et bariatrique AP-HP - Hôpital Bichat - Claude-Bernard 46 Rue Henri Huchard 75018 PARIS

Paris, 75018, France

RECRUITING

Département de chirurgie viscérale CHU de Poitiers 2 Rue de la Miletrie - CS 90577 - 86000 POITIERS

Poitiers, 86000, France

RECRUITING

Clinique Chirurgicale Mutualiste 3 rue le verrier - BP 209 42100 SAINT ETIENNE

Saint-Etienne, 42100, France

RECRUITING

Département de chirurgie digestive et endocrinienne CHU de Strasbourg - Nouvel Hôpital civil Rez-de-chaussée 1 place de l'hôpital BP 426 67091 STRASBOURG cedex

Strasbourg, 67091, France

RECRUITING

Service de Chirurgie Digestive Hôpital Rangueil - CHU de Toulouse 1 avenue du Pr Jean Poulhès - TSA 50032 31059 TOULOUSE Cedex 9

Toulouse, 31059, France

RECRUITING

Département de Chirurgie Viscérale Métabolique et Cancérologique Responsable de l'Unité de Chirurgie Endocrinienne Université de Lorraine CHRU de Nancy - Hôpital Brabois adultes 11 allée du Morvan 54511 VANDOEUVRE LES NANCY

Vandœuvre-lès-Nancy, 54511, France

RECRUITING

MeSH Terms

Conditions

Obesity

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Maud ROBERT, MD, PHD

CONTACT

Dominique DELAUNAY, MD, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single-blind study: patient will not be informed of the approach (laparoscopic or robotic) which will be used for their intervention.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Prospective multicenter randomized, controlled in 2 parallel groups, single-blind, superiority trial comparing 2 modalities of bariatric surgery (first-line or revision): * Robotic surgical strategy * Conventional laparoscopic surgical strategy
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2025

First Posted

March 5, 2025

Study Start

July 25, 2025

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

July 31, 2025

Record last verified: 2025-07

Locations